Company
Insilico Medicine
HKEX:3696
Generative-AI drug discovery (Pharma.AI).
At a glance
- Listing
- HKEX:3696
- Category
- AI drug discovery
- Headquarters
- Hong Kong / Boston
- Market cap
- ~HK$23–24B (US$3.0B)
Thesis
Why it is in this universe
- Category
- AI drug discovery
- Market
- Global
- Recent inflection
- IPO 30 Dec 2025, largest 2025 HK biotech IPO; Temasek cornerstone.
- Services
- None recorded
- People tracked
- None on file
Market data
Listing and scale
| Metric | Detail |
|---|---|
| Exchange | HKEX |
| Ticker | HKEX:3696 |
| Secondary listing | None |
| Market cap | ~HK$23–24B (US$3.0B) |
| Status | Listed and trading |
Editor's noteA listing or financing event is not a clinical result. variis grades evidence on the linked protocol, not the share price.
Get in touch
Contact
- Address
- Hong Kong / Boston
- Website
- www.prnewswire.com
- Phone
- No public number published
- No public address published
Offering
What it sells today
No commercial services are recorded for this company yet.
Recent inflection
What moved lately
IPO 30 Dec 2025, largest 2025 HK biotech IPO; Temasek cornerstone.
Common questions
- Why does variis track Insilico Medicine?
- Generative-AI drug discovery (Pharma.AI).
- Is Insilico Medicine publicly listed?
- Yes. It trades as HKEX:HKEX:3696. Market capitalisation is in the ~HK$23–24B (US$3.0B) range, recorded as a dated snapshot rather than a live quote.
- Where is Insilico Medicine based?
- Hong Kong / Boston
- Is Insilico Medicine still trading?
- Insilico Medicine is recorded as actively trading.
Latest moves
Dated developments variis is tracking.
Keep reading
Related coverage from the newsroom.
Every entity profile on variis is sourced. Not investment advice.